Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values.
Auteurs : Paquier Z, Chao SL, Acquisto A, Fenton C, Guiot T, Dhont J, Levillain H, Gulyban A, Bali MA, Reynaert N Année : 2022 Journal : Biomed Phys Eng Express
HDR brachytherapy boost using MR-only workflow for intermediate- and high-risk prostate cancer: 8-year results of a pilot study.
Auteurs : Lakosi F, Antal G, Pall J, Farkas A, Jenei T, Nagy D, Liptak J, Sipocz I, Pytel A, Csima M, Gulyban A, Toller G Année : 2021 Journal : Brachytherapy
Correction to: Combined quality and dose-volume histograms for assessing the predictive value of <sup>99m</sup>Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.
Auteurs : Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, Vouche M, Flamen P, Reynaert N Année : 2021 Journal : EJNMMI Phys
Linac-based stereotactic ablative radiotherapy for pancreatic cancer with intrafractional triggered imaging.
Auteurs : Kisiván K, Erdélyesi D, Gutyina D, Sajti P, Gugyerás D, Farkas A, Glavák C, László Z, Somogyiné Ezer É, Máhr K, Szabó Z, Szabó H, Cselik Z, Gulyban A, Káposztás Z, Lakosi F Année : 2021 Journal : Magy Onkol
Monte Carlo as quality control tool of stereotactic body radiation therapy treatment plans.
Auteurs : Alhamada H, Simon S, Gulyban A, Gastelblum P, Pauly N, VanGestel D, Reynaert N Année : 2021 Journal : Phys Med